Xue-Feng Pei

Title: The Innovative Mind of Xue-Feng Pei

Introduction

Xue-Feng Pei, a prolific inventor based in Lansdale, Pennsylvania, has made significant contributions to the field of pharmacology through his groundbreaking patents. With a total of three patents to his name, he has focused on developing compositions that act as antagonists of excitatory amino acid receptors, which have important therapeutic applications for various neuropsychopharmacological disorders.

Latest Patents

Pei's latest patents highlight his innovative approach to addressing issues related to non-NMDA ionotropic excitatory amino acid (EAA) receptor activation. His first notable patent, "Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors," introduces sulfur-containing dihydrophthalazine compositions. These compounds are effective in treating disorders linked to excessive activation of the non-NMDA subtype of ionotropic EAA receptors. They serve as therapeutic agents for conditions such as stroke, ischemia, and epilepsy, and may be administered orally or parenterally.

Similarly, his second patent, "5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors," presents substituted benzodiazepine compositions with similar efficacy against non-NMDA EAA receptors. These 7- or 8-mono substituted 5H-2,3-benzodiazepines not only provide potential treatment options for neuropsychopharmacological disorders but also serve as testing agents to identify additional therapeutic compounds.

Career Highlights

Xue-Feng Pei is affiliated with Transgenomic, Inc., where his research and innovations continue to impact the pharmaceutical landscape. His work exemplifies a commitment to advancing medical science through the development of novel therapeutic agents. With three patents reflecting his expertise, Pei stands out as a valuable inventor in the industry.

Collaborations

Throughout his career, Pei has collaborated with notable colleagues, including Baoqing Li and Maria-Luisa Maccecchini. These partnerships have undoubtedly enriched his research and contributed to the successful development of his patented inventions.

Conclusion

Xue-Feng Pei's inventive spirit and dedication to improving health outcomes underscore the importance of patents in fostering innovation. His work on non-NMDA EAA receptor antagonists not only opens new avenues in therapeutic applications but also highlights the collaborative efforts of researchers in the pursuit of medical advancements. Through his contributions, Pei continues to inspire the next generation of inventors in the field of pharmacology.